The predictive and prognostic significance of cell-free DNA concentration in melanoma.
Renata VaraljaiS EloualiS S LueongK Wistuba-HamprechtT SeremetJ T SivekeJ C BeckerA SuckerA PaschenP A HornB NeynsB WeideDirk SchadendorfAlexander RoeschPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
We provide evidence that total cfDNA can be used as a biomarker for melanoma irrespective of the tumour genotype and can provide information on tumour load, risk of progression and risk of death.